We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Christian Hammer - Principal Scientist, Cancer Immunology & Human Genetics

Christian Hammer

Principal Scientist, Cancer Immunology & Human Genetics

"The work of a Human Geneticist, while exciting and impactful, can be highly theoretical and somewhat detached from the very reason you entered science in the first place. At Genentech, I thoroughly enjoy the opportunity to do discovery research while at the same time collaborating with brilliant interdisciplinary colleagues along the full translational spectrum from bench to bedside."
4
Years at Genentech
14
Publications
4
Awards & Honors

With a background in complex trait genomics, I joined Genentech in 2017 after post-doctoral work at the Max Planck Institute of Experimental Medicine in Göttingen, Germany, and at EPFL in Lausanne, Switzerland. As a scientist in our Cancer Immunology and Human Genetics departments I investigate how inherited genetic variation in immune-relevant genes shape patients’ responses to cancer immunotherapies.

Featured Publication

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.

Nat Rev Cancer 21, 298–312 (2021).

Jhunjhunwala, S., Hammer, C. & Delamarre, L.

Genetic variation associated with thyroid autoimmunity shapes the systemic immune response to PD-1 checkpoint blockade.

Nat Commun 12, 3355 (2021).

Khan, Z., Hammer, C., Carroll, J. et al.

MiDAS—Meaningful Immunogenetic Data at Scale.

PLOS Computational Biology 17(7): e1009131.

Migdal M, Ruan DF, Forrest WF, Horowitz A, Hammer C.